CN113647488A - High-tea-brown-element tea extract and preparation process thereof - Google Patents
High-tea-brown-element tea extract and preparation process thereof Download PDFInfo
- Publication number
- CN113647488A CN113647488A CN202110963932.6A CN202110963932A CN113647488A CN 113647488 A CN113647488 A CN 113647488A CN 202110963932 A CN202110963932 A CN 202110963932A CN 113647488 A CN113647488 A CN 113647488A
- Authority
- CN
- China
- Prior art keywords
- tea
- soup
- strain
- theabrownin
- tea soup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 11
- 238000000605 extraction Methods 0.000 title description 10
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 123
- 235000013616 tea Nutrition 0.000 claims abstract description 103
- 235000014347 soups Nutrition 0.000 claims abstract description 59
- 235000019225 fermented tea Nutrition 0.000 claims abstract description 30
- 238000001914 filtration Methods 0.000 claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 24
- 230000004151 fermentation Effects 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000009569 green tea Nutrition 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000011081 inoculation Methods 0.000 claims abstract description 14
- 241000228232 Aspergillus tubingensis Species 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 241000233866 Fungi Species 0.000 claims abstract description 11
- 238000000227 grinding Methods 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000011089 carbon dioxide Nutrition 0.000 claims abstract description 7
- 238000009777 vacuum freeze-drying Methods 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000000725 suspension Substances 0.000 claims abstract description 5
- 239000008223 sterile water Substances 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 3
- 238000012216 screening Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 9
- 239000000049 pigment Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- CQIUKKVOEOPUDV-IYSWYEEDSA-N antimycin Chemical compound OC1=C(C(O)=O)C(=O)C(C)=C2[C@H](C)[C@@H](C)OC=C21 CQIUKKVOEOPUDV-IYSWYEEDSA-N 0.000 claims description 5
- CQIUKKVOEOPUDV-UHFFFAOYSA-N citrinine Natural products OC1=C(C(O)=O)C(=O)C(C)=C2C(C)C(C)OC=C21 CQIUKKVOEOPUDV-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000008188 pellet Substances 0.000 claims description 5
- 238000012163 sequencing technique Methods 0.000 claims description 5
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 206010067484 Adverse reaction Diseases 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 108090000704 Tubulin Proteins 0.000 claims description 3
- 230000006838 adverse reaction Effects 0.000 claims description 3
- 208000036815 beta tubulin Diseases 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 229930183344 ochratoxin Natural products 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 241001249699 Capitata Species 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 102000000131 Beta tubulin Human genes 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 235000020344 instant tea Nutrition 0.000 abstract description 11
- 239000000047 product Substances 0.000 abstract description 10
- 235000013361 beverage Nutrition 0.000 abstract description 5
- 238000002386 leaching Methods 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 3
- 230000036449 good health Effects 0.000 abstract description 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000007790 scraping Methods 0.000 abstract 1
- 102000004157 Hydrolases Human genes 0.000 description 10
- 108090000604 Hydrolases Proteins 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000956 nontoxicity Toxicity 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000030523 Catechol oxidase Human genes 0.000 description 2
- 108010031396 Catechol oxidase Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 2
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 231100000033 toxigenic Toxicity 0.000 description 2
- 230000001551 toxigenic effect Effects 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- -1 polyphenol compounds Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000008118 thearubigins Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
- A23F3/26—Drying or concentrating tea extract by lyophilisation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Tea And Coffee (AREA)
Abstract
A method for producing instant tea powder with high theabrownin content from side tea of green tea is provided. Putting the auxiliary green tea into water with the volume 60 times of the room temperature, leaching in a boiling water bath for 30 minutes, filtering, and fixing the volume to obtain the tea soup. Filtering the tea soup with gauze for 2 times, filtering with filter paper for 1 time, cooling to room temperature, and sterilizing with 0.22um sterilizing membrane to obtain the final product. Scraping spores of fermentation fungus strain Aspergillus tubingensis strain M-2 into sterile water, and continuously adjusting to spore suspension concentration of 1.0 × 106CFU/mL, namely obtaining inoculation liquid. Transferring the inoculation liquid into the initial sterile tea soup according to the volume ratio of 2%, performing shaking culture at the speed of 80r/min for 5 days at room temperature to obtain fermented tea soup, filtering and sterilizing the fermented tea soup, performing vacuum freeze drying, and grinding the dried solid matter with dry ice to obtain the finished product. The instant tea has the advantages of rapid and thorough dissolution, high theabrownin content, and bright and transparent soup colorThe tea solid beverage has the advantages of brightness, and the like, is a novel portable tea solid beverage with bioactivity, and has good health care effect.
Description
Technical Field
The invention belongs to the technical field of preparation of instant tea delicacies, and relates to a preparation process of high-theabrownin tea delicacies and high-theabrownin tea delicacies prepared by the preparation process.
Background
The instant tea is a powdered tea material prepared by using black tea, green tea, scented tea or oolong tea as raw materials and processing the raw materials through the technical processes of extraction, filtration, concentration (and drying) and the like, and can be widely applied to foods and tea beverages in different forms. A portable solid tea beverage having tea flavor contains tea polyphenols, theanine, caffeine, etc. The instant tea can adapt to the fast-paced life of the modern times, has strong plasticity and convenient allocation, and is more and more popular in the market.
The secondary green tea is a general term of tea flakes, tea dust, tea stem and the like formed in the processing process of green tea, accounts for about 10% of the finished tea, has the characteristics of poor content ratio, low fragrance, light and thin taste, peculiar smell and the like, is difficult to sell through the traditional tea consumption channel, and is a main byproduct generated in the processing process of the tea. The secondary green tea is one of the main raw materials for deep processing of tea due to the characteristics of similar content to that of the traditional finished tea, low price, easy obtainment and the like. If the secondary green tea is used as a raw material, the deep processing and utilization approaches of the secondary green tea are expanded, which has great significance for the sustainable development of the tea industry.
The tea pigment is a water-soluble pigment mixture derived from oxidation of polyphenol compounds mainly comprising catechin in tea, and comprises theaflavin, thearubigin and theabrownin. The studies show that theabrownin is the most stable and the bioactivity is the greatest. Particularly, theabrownin has the function of remarkably inhibiting protein tyrosine phosphatase, and can be used for treating and preventing type II diabetes, obese diabetes and obesity; has effects in regulating blood lipid, resisting atherosclerosis, removing speckle, caring skin, preventing cancer, and preventing ultraviolet irradiation; has strong free radical scavenging activity and antioxidant effect; has no toxic and side effects, and is safe and reliable to take.
The existing theabrownin extraction method mainly comprises an extraction method and a microbial fermentation method. Wherein CN102334574 discloses an extraction method, and the optimal yield of theabrownin extracted by an organic solvent can reach 22.92%. CN101455257 discloses a microbial fermentation method, which states that the extract of the method has a theabrownin content of 14.50-18.28% by chemical composition analysis. CN102258099 also discloses a microbial fermentation process. The patent states that the theabrownin content of the extract obtained by the method is (60.45 +/-1.5)%, by chemical composition analysis. The method has the defects of low theabrownin extraction rate, high extraction cost, long preparation time, easy pollution by aspergillus, excessive use of organic solvents and the like.
Based on the analysis, an instant tea beverage which can make full use of the side tea of green tea and has high theabrownin content is urgently needed in the industry at present. Not only can fully utilize the byproducts of the tea, but also can reduce the production cost.
Disclosure of Invention
Theabrownines are generally mainly extracted from dark tea, but most of the dark tea is prepared by adopting the traditional solid-state' pile fermentation process at present, and the fermentation process has the problems of low production efficiency, serious restriction by natural conditions, long production period, uneven theaabrownines content, easy pollution of mixed bacteria in the production process and the like. In view of the above disadvantages, the present invention aims to provide a method for preparing an instant tea beverage with high theabrownin content, which uses the secondary green tea as the main raw material, has the advantages of simple production process, easily controllable production conditions, low fermentation cost, and capability of significantly increasing the theabrownin content, and is suitable for industrial scale production.
The invention is realized by the following means:
a preparation process of high theabrownin tea extract comprises the following steps:
leaching the secondary green tea in boiling water bath for 30min, filtering, cooling and sterilizing to obtain initial sterile tea soup;
inoculating bacteria liquid to the initial sterile tea soup, and fermenting to obtain fermented tea soup; and
and pre-freezing the fermented tea soup, performing low-temperature vacuum drying, and grinding by dry ice to obtain the high-theabrownin tea delicacies.
Further, the secondary green tea includes, but is not limited to, tea flakes, tea dust, and tea capitata.
Further, the mass volume ratio of the auxiliary green tea to the room temperature water is 1:60, boiling water bath is carried out for 30min, and initial tea soup is obtained by filtering; the pH value of the initial tea soup is natural.
Further, the filtering comprises three times of filtering, which are respectively: gauze filtration, and filter paper filtration.
Further, the sterilization treatment comprises the following steps: the initial tea broth was sterilized by filtration through a 0.22 μm filter.
Further, the inoculation liquid is prepared by the following method:
the Yaan dark green tea pile fermentation sample is taken as a raw material, the tea leaves are soaked in sterile water and then spread on a PDA flat plate, the constant temperature culture is carried out at 28 ℃, and the fungus strain is obtained through separation and purification;
inoculating the purified fungus strain into a PDB culture medium, carrying out shaking culture at 28 ℃ and 120r/min for 2 days, taking mycelium pellets, freezing in liquid nitrogen, quickly grinding into powder, extracting the genomic DNA of the strain according to a fungus genomic DNA extraction kit provided by Beijing Solebao science and technology Co., Ltd, and carrying out PCR amplification on ITS and beta-tubulin sequences. Storing the amplified product at 4 ℃, sending the amplified product to a biological engineering (Shanghai) corporation for sequencing, carrying out homology comparison (http:// www.ncbi.nlm.nihgov/blast.cgi) on the sequencing result and sequences in a GenBank database, selecting the sequences with the homology of more than 99 percent, constructing a phylogenetic tree by using MEGA 7.0 software, and determining the category of the fungal strain;
on the basis, strains are screened, and the specific process is as follows: screening out strains which have the prior toxin production and produce adverse reaction reports on human bodies; fermenting the initial tea soup by using the residual purified strains, respectively detecting ochratoxin and citrinin in the fermented tea soup by referring to national standard GB 5009.96-2016 (determination of ochratoxin A in national food safety standards) and national standard GB 5009.222-2016 (determination of citrinin in national food safety standards), and screening out toxigenic strains; measuring the tea pigment in the fermented tea soup of the strains obtained after the second screening, analyzing the capability of each strain for converting the tea pigment, and reserving the strains with high yield of the theabrownin, namely the fermented strains;
determining polyphenol oxidase activity of the fermentation strain by measuring the content of theabrownin in the fermented tea soup, and sequentially measuring the activities of starch hydrolase, protein hydrolase and tannin hydrolase of the fermentation strain by adopting an amylase screening culture medium, a protease screening culture medium and a tannin enzyme screening culture medium;
the Aspergillus tubingensis strain M-2 is obtained by screening, has the characteristics of stable heredity, no toxicity, safety, reliability, high activity of hydrolase and oxidase and the like, and is an excellent fermentation strain;
the A.tubingensis strain M-2 was activated and prepared in a spore suspension concentration of 1.0X 106CFU/mL inoculation solution.
Further, the inoculation amount of the inoculation liquid is 2% of the volume of the sterilized tea soup.
Further, the fermentation treatment comprises: culturing at room temperature at 80r/min under shaking for 5 days, and filtering to remove mycelium pellet.
Further, the low-temperature freeze drying conditions are as follows: freezing the fermented tea soup in a refrigerator at-20 deg.C, transferring into a vacuum freeze-drying machine, drying at vacuum state (about 1pa) and-40 deg.C until water in the fermented tea soup is completely lost, rapidly and fully grinding the dried solid with dry ice to obtain fine powder, and collecting the powder to obtain the high-theabrownin tea beverage.
The invention also discloses the high-theabrownin tea delicacies prepared by any one of the preparation processes.
The invention has the beneficial effects that:
1. the fermentation fungus Aspergillus tubingensis strain M-2 is obtained by separating, purifying and screening a big pile sample produced by the traditional black tea, has the characteristics of no toxicity production, safety, reliability, high hydrolase and oxidase activity and the like, can fully utilize the tea content substances for metabolism, can quickly convert the tea content substances and the like, is the best fermentation strain which is screened from hundreds of fungi and has the capability of preparing instant tea juice by fermenting the side tea soup of the green tea, and the catechin of the fermented tea soup is fully converted into theabrownin.
2. The tea soup prepared by fermenting the green tea side tea by using the fermentation fungus Aspergillus tubingensis strain M-2 is quickly converted to obtain the beneficial nutrient component of theabrownin, and the tea soup is treated by a vacuum freeze drying technology, so that the tea soup contains primary and secondary metabolic active products of Aspergillus tubingensis, and has good health care effects on the aspects of digestion elimination, greasiness removal and gastrointestinal function conditioning. The fermented instant tea beverage has rich theabrownin content, and has health promotion effects of regulating blood lipid and preventing cardiovascular diseases.
3. The green tea raw materials in the invention have wide sources and low price, and the prepared instant tea powder has high theabrownin yield and strong biological activity. The fermentation process flow is simple, the operation is controllable, no harmful solvent is left, the preparation technology is green and energy-saving, and the sanitation index and the physical and chemical index of the product are high.
Detailed description of the preferred embodiments
Example 1
Adding tea auxiliary tea (including tea tablet, tea powder, tea of fructus Toosendan, etc.) into water, wherein the ratio of tea to water is 1:60 (g/mL), natural pH value, 30 minutes of boiling water bath extraction, and obtaining the initial tea soup by three times of filtration (gauze filtration, gauze filtration and filter paper filtration) when the extraction is finished. Sterilizing the initial tea soup cooled to room temperature with 0.22um filter membrane to obtain the initial sterilized tea soup. Activating the selected Aspergillus tubingensis strain M-2 with high hydrolase and oxidase activity, and making into spore suspension with concentration of 1.0 × 106CFU/mL inoculation solution. Inoculating the inoculation liquid into the initial sterilized tea soup according to 2% of the volume of the initial sterilized tea soup, carrying out oscillation culture at the speed of 80r/min for 5 days at room temperature, carrying out suction filtration to remove mycelium clusters, thus obtaining the high-theabrownin fermented tea soup, completely freezing the high-theabrownin fermented tea soup in a refrigerator at the temperature of-20 ℃, transferring the high-theabrownin fermented tea soup into a vacuum freeze dryer, drying the high-theabrownin fermented tea soup at the temperature of vacuum state (about 1pa) and-40 ℃ until the water in the fermented tea soup is completely lost, rapidly and fully grinding the dried solid matter with dry ice to obtain fine powder, and collecting the powder, thus obtaining the high-theabrownin tea soup.
Specifically, the inoculation liquid used in the embodiment is prepared by the following method:
the Yaan dark green tea pile fermentation sample is taken as a raw material, the tea leaves are soaked in sterile water and then spread on a PDA flat plate, the constant temperature culture is carried out at 28 ℃, and the fungus strain is obtained through separation and purification;
inoculating the purified fungus strain into a PDB culture medium, carrying out shaking culture at 28 ℃ and 120r/min for 2 days, taking mycelium pellets, freezing in liquid nitrogen, quickly grinding into powder, extracting the genomic DNA of the strain according to a fungus genomic DNA extraction kit provided by Beijing Solebao science and technology Co., Ltd, and carrying out PCR amplification on ITS and beta-tubulin sequences. Storing the amplified product at 4 ℃, sending the amplified product to a biological engineering (Shanghai) corporation for sequencing, carrying out homology comparison (http:// www.ncbi.nlm.nihgov/blast.cgi) on the sequencing result and sequences in a GenBank database, selecting the sequences with the homology of more than 99 percent, constructing a phylogenetic tree by using MEGA 7.0 software, and determining the category of the fungal strain;
on the basis, strains are screened, and the specific process is as follows: screening out strains which have the prior toxin production and produce adverse reaction reports on human bodies; fermenting the initial tea soup by using the residual purified strains, respectively detecting ochratoxin and citrinin in the fermented tea soup by referring to national standard GB 5009.96-2016 (determination of ochratoxin A in national food safety standards) and national standard GB 5009.222-2016 (determination of citrinin in national food safety standards), and screening out toxigenic strains; measuring the tea pigment in the fermented tea soup of the strains obtained after the second screening, analyzing the capability of each strain for converting the tea pigment, and reserving the strains with high yield of the theabrownin, namely the fermented strains;
determining polyphenol oxidase activity of the fermentation strain by measuring the content of theabrownin in the fermented tea soup, and sequentially measuring the activities of starch hydrolase, protein hydrolase and tannin hydrolase of the fermentation strain by adopting an amylase screening culture medium, a protease screening culture medium and a tannin enzyme screening culture medium;
the Aspergillus tubingensis strain M-2 is obtained by screening, has the characteristics of stable heredity, no toxicity, safety, reliability, high activity of hydrolase and oxidase and the like, and is an excellent fermentation strain;
the A.tubingensis strain M-2 was activated and prepared in a spore suspension concentration of 1.0X 106CFU/mL inoculation solution.
Comparative example 1
Compared with the example 1, the fermentation step is eliminated, and the method specifically comprises the following steps:
adding tea auxiliary tea (including tea tablet, tea powder, tea of fructus Toosendan, etc.) into water at a tea-water ratio of 1:60 (g/mL), pH 7.0, leaching in a boiling water bath for 30 minutes, and filtering for three times (gauze filtration, gauze filtration and filter paper filtration) when the leaching is finished to obtain the initial tea soup. Sterilizing the initial tea soup cooled to room temperature with 0.22um filter membrane to obtain the initial sterilized tea soup. Completely freezing the initial sterilized tea soup in a refrigerator at-20 deg.C, transferring into a vacuum freeze-drying machine, drying at vacuum state (about 1pa) and-40 deg.C until the water in the fermented tea soup is completely lost, rapidly and fully grinding the dried solid with dry ice to obtain fine powder, and collecting the powder to obtain the high-theabrownin tea.
Test example 1
Comparing the theabrownin content and sensory evaluation of the two fermented tea soups
TABLE 1 Theabrownine content determination and sensory evaluation results in fermented tea soup
Grouping | Theabrownin (%) | Fragrance | Color and luster of tea soup | Taste of the product |
Example 1 | 18.98 | Sweet, old and tea fragrance | Brownish red and bright | Sweet and tasty |
Comparative example 1 | 7.16 | Tea fragrance with slight sweet smell | Deep apricot yellow and lack of brightness | Sweet and tasty |
As can be seen from the data in Table 1, the theabrownin content of example 1 is significantly higher than that of the control group, and meanwhile, the instant tea extract prepared by using the Aspergillus tubingensis strain M-2 shows instant property after being brewed in cold and hot water, and has better fragrance and taste than the control group, obvious old fragrance, sweet fragrance and tea fragrance, and no odor and mildew taste. The vacuum freeze drying does not damage the substances in the fermented tea soup, and the finished product of the tea treasure contains the primary and secondary metabolic active products of the aspergillus tubingensis, thus the tea treasure is a novel solid tea drink with health care efficacy.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.
Claims (10)
1. A preparation process of high theabrownin tea extract comprises the following steps:
extracting the auxiliary green tea with water for 30min, filtering, cooling, and sterilizing to obtain sterile tea soup;
inoculating bacteria liquid to the initial sterile tea soup, and fermenting to obtain fermented tea soup; and
the fermented tea soup is pre-frozen, then is subjected to vacuum freeze drying, and is ground by dry ice to obtain the high-theabrownin tea delicacies.
2. The production process according to claim 1, wherein:
the secondary tea of green tea includes, but is not limited to, tea flakes, tea dust and tea capitata.
3. The production process according to claim 1, wherein:
the mass volume ratio of the auxiliary green tea to the room temperature water is 1:60, boiling water bath is carried out for 30min, and initial tea soup is obtained by filtering.
4. The production process according to claim 1, wherein:
the filtration comprises three times of filtration, which are respectively as follows: gauze filtration, and filter paper filtration.
5. The production process according to claim 1, wherein:
the sterilization treatment comprises the following steps: the initial tea broth was sterilized through a 0.22um filter.
6. The production process according to claim 1, wherein:
the inoculation liquid is prepared by the following method:
the Yaan dark green tea pile fermentation sample is taken as a raw material, the tea leaves are soaked in sterile water and then spread on a PDA flat plate, the constant temperature culture is carried out at 28 ℃, and the fungus strain is obtained through separation and purification;
inoculating the purified fungus strain into PDB culture medium, performing shake culture at 28 deg.C and 120r/min for 2 days, freezing mycelium pellet in liquid nitrogen, and rapidly grinding into powder;
extracting genome DNA of the strain, amplifying ITS and beta-tubulin sequences by PCR, storing and sequencing the amplification product at 4 ℃, and determining the species name of the fungus strain by combining the two sequence information;
screening out strains which have the prior toxin production and generate adverse reaction reports to human bodies, fermenting the initial tea soup by using the residual purified strains, detecting ochratoxin and citrinin in the fermented tea soup, and screening out the toxin production strains;
measuring the tea pigment in the fermented tea soup of the strains obtained after the second screening, analyzing the capability of each strain for converting the tea pigment, and reserving the strains with high yield of the tea pigment, namely the fermentation strain Aspergillus tubingensis strain M-2;
the A.tubingensis strain M-2 was activated and prepared in a spore suspension concentration of 1.0X 106CFU/mL inoculation solution.
7. The production process according to claim 1, wherein:
the inoculation amount of the inoculation liquid is 2% of the volume of the sterilized tea soup.
8. The production process according to claim 1, wherein:
the fermentation treatment comprises the following steps:
culturing at room temperature at 80r/min under shaking for 5 days, and filtering to remove mycelium pellet.
9. The production process according to claim 1, wherein:
the low-temperature freeze drying conditions are as follows:
pre-freezing the fermented tea soup at-20 deg.C, transferring into vacuum freeze-drying machine, and drying at-40 deg.C under vacuum condition until water in the fermented tea soup is completely lost;
fully grinding the dried solid matter by using dry ice until fine powder is obtained; and
collecting the powder to obtain the high-theabrownin tea.
10. A high theabrownin tea delicacy prepared according to the preparation process of any one of claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110963932.6A CN113647488A (en) | 2021-08-21 | 2021-08-21 | High-tea-brown-element tea extract and preparation process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110963932.6A CN113647488A (en) | 2021-08-21 | 2021-08-21 | High-tea-brown-element tea extract and preparation process thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113647488A true CN113647488A (en) | 2021-11-16 |
Family
ID=78481559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110963932.6A Pending CN113647488A (en) | 2021-08-21 | 2021-08-21 | High-tea-brown-element tea extract and preparation process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113647488A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105685298A (en) * | 2016-01-29 | 2016-06-22 | 四川农业大学 | Processing method of dark tea aspergillus fermentation liquid tea drink |
CN105707623A (en) * | 2016-01-29 | 2016-06-29 | 四川农业大学 | Processing method of microbial fermentation liquid black tea beverage |
CN106167765A (en) * | 2016-06-03 | 2016-11-30 | 云南农业大学 | A kind of method that Tabin aspergillus and liquid fermentation thereof produce abrownin |
CN106635820A (en) * | 2016-02-29 | 2017-05-10 | 安徽农业大学 | Aspergillus niger yielding large amount of theabrownin and application of aspergillus niger |
CN109136100A (en) * | 2018-08-21 | 2019-01-04 | 鑫鼎生物科技有限公司 | One plant of Tabin aspergillus bacterial strain and the application on fermentation green brick tea |
CN109198073A (en) * | 2018-07-13 | 2019-01-15 | 云南中茶茶业有限公司 | One plant of Tabin aspergillus bacterial strain and its application for promoting Pu'er tea quality |
-
2021
- 2021-08-21 CN CN202110963932.6A patent/CN113647488A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105685298A (en) * | 2016-01-29 | 2016-06-22 | 四川农业大学 | Processing method of dark tea aspergillus fermentation liquid tea drink |
CN105707623A (en) * | 2016-01-29 | 2016-06-29 | 四川农业大学 | Processing method of microbial fermentation liquid black tea beverage |
CN106635820A (en) * | 2016-02-29 | 2017-05-10 | 安徽农业大学 | Aspergillus niger yielding large amount of theabrownin and application of aspergillus niger |
CN106167765A (en) * | 2016-06-03 | 2016-11-30 | 云南农业大学 | A kind of method that Tabin aspergillus and liquid fermentation thereof produce abrownin |
CN109198073A (en) * | 2018-07-13 | 2019-01-15 | 云南中茶茶业有限公司 | One plant of Tabin aspergillus bacterial strain and its application for promoting Pu'er tea quality |
CN109136100A (en) * | 2018-08-21 | 2019-01-04 | 鑫鼎生物科技有限公司 | One plant of Tabin aspergillus bacterial strain and the application on fermentation green brick tea |
Non-Patent Citations (1)
Title |
---|
胥伟;姜依何;吴丹;赵仁亮;朱旗;: "高通量测序研究霉变黑毛茶的真菌多样性" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104388514B (en) | The method that gamma aminobutyric acid is prepared using composite bacteria fermentation | |
CN103243040B (en) | Bacillus subtilis LSSE-22 and application thereof | |
CN113604395B (en) | Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof | |
CN113143812B (en) | Preparation method of kava pepper fermentation product, kava pepper fermentation product and application of kava pepper fermentation product in cosmetics | |
CN111808769B (en) | Lactobacillus brevis and application thereof in grapefruit fermentation and cosmetics | |
KR101562653B1 (en) | Bacillus subtilis CS135 strain and preparation method of Chounggukjang containing Momordica charantia using the same | |
CN112877257B (en) | Bacillus licheniformis and application thereof | |
CN105670936B (en) | A kind of method of Trametes trogii bacterial strain and its application and Pu'er tea processing | |
KR101189659B1 (en) | Functional feed using natural materials and manufacturing the functional feed | |
CN111040958B (en) | Preparation method of fermentation product with multiple physiological function activities and special bacillus amyloliquefaciens thereof | |
CN113308419B (en) | Lactobacillus chaff for fermentation and application thereof | |
CN108570422A (en) | One plant of lactobacillus buchneri bacterial strain and its ensilage fermentation agent | |
CN113647488A (en) | High-tea-brown-element tea extract and preparation process thereof | |
KR101885207B1 (en) | Method for processing coffee cherry using deep sea water and microbes | |
CN113308418B (en) | Lactobacillus chaff for fermentation and fermentation preparation process thereof | |
CN112940967B (en) | Lactobacillus fermentum MF423, fermented rice bran extract thereof and application of lactobacillus fermentum MF423 and fermented rice bran extract | |
CN114468074A (en) | Application of lactobacillus plantarum A4 in Tibetan tea production and Tibetan tea preparation method | |
CN113648254A (en) | Lupinus acutus and cherry fermentate for cosmetics and preparation method thereof | |
CN102805171A (en) | Process for utilizing tea comprehensively | |
KR101063624B1 (en) | Schizandra fermented product, fermentation method thereof and food composition comprising the fermented product | |
CN111154599A (en) | Antioxidant bean dreg white spirit brewing method | |
CN109810918A (en) | One plant of atrophy bacillus, bacteria agent and its application for having preventive effect to fructus lycii leaf blight | |
CN115137003B (en) | Solid-state fermentation jujube bud tea and preparation method thereof | |
CN115089529B (en) | Mung bean hull fermentation product with acne removing effect, and preparation method and application thereof | |
WO2024139133A1 (en) | Efficient degrading microorganism sl006 for rosa roxburghii tratt tannin and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211116 |